Oncocyte Corporation (OCX) Q4 2021 Earnings Call

Investor webinar replay

Meeting Overview The Oncocyte Corporation held a conference call to discuss their 4th quarter and full year 2021 financial results, along with recent operational highlights. Key topics included strategic advancements, product launches, and financial performance amidst challenges posed by the COVID-19 pandemic. Key Discussion Points - Overview of 2021 financial results and operating highlights. - Discussion of forward-looking statements and associated risks. - Presentation of the DETERMA platform strategy and product development timeline. - Updates on major products: Determi-IO, Determi-TX, Determi-RX, and DetermiCNI. - Progress in the transplant monitoring business following the acquisition of Chronix Biomedical. - Growth in revenue and physician onboarding for the TermaRx product. - Milestone achievements, including the launch of Determiner X in China. Decisions Made - No explicit decisions recorded. Action Items & Next Steps - [Unassigned] : Continue to track the progress of produ...

Watch the replay

Replay transcript excerpt

[Speaker identities could not be resolved; generic labels used] [00:00] Speaker 1: Greetings. Welcome to the Oncocyte Corporation 4th 0.25 and full year 2021 earnings conference call. At this time, all participants are in a listen-only mode. A question and answer session will follow the formal presentation. [00:12] Speaker 1: If anyone should require operator assistance During the conference, please press star 0 on your telephone keypad. [00:19] Speaker 1: Please note this conference is being recorded. [00:21] Speaker 1: I'll now turn the conference over to your host, Troy Williams of Lifesci Advisors. You may begin. [00:27] Speaker 2: Thank you, Kyle. And thank you, everyone, for joining us for today's conference call to discuss Oncocyte's 4th 0.25 and year-end 2021 [00:35] Speaker 2: financial results and recent operating highlights. If you have not seen today's financial results press releases, [00:42] Speaker 2: please visit the investors page on the company's website. [00:46] Speaker 2: Before turning the call over to Ronnie Andrews, ONCASID's President and Chief Executive Officer, I would like to remind you that during this conference call, the company will make projections and forward-looking statements regarding future events. [00:59] Speaker 2: Any statements that are not historical facts are forward-looking statements. [01:03] Speaker 2: We encourage you to review the company's SEC filings including without limitation the company's forms 10-K and 10-Qs [01:11] Speaker 2: which identifies specific risk factors that may cause actual results or events to differ materially [01:17] Speaker 2: from those described in these 4 looking statements. [01:21] Speaker 2: These factors may include without limitation [01:23] Speaker 2: risks inherent in the development and...